SHH Resources Holdings Berhad (KLSE:SHH)

Verve Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 23, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	135	125	86	48	60	19
Market Cap Growth	-1.63%	45.35%	79.17%	-20.00%	211.69%	-11.49%
Enterprise Value	112	102	68	47	64	6
Last Close Price	1.35	1.24	0.85	0.48	0.60	0.19
PE Ratio	54.76	24.63	23.16	9.32	15.12	-
Forward PE	-	8.13	8.13	8.13	8.13	8.13
PS Ratio	1.63	1.56	1.04	0.52	0.53	0.19
PB Ratio	1.62	1.51	1.11	0.65	0.87	0.30
P/TBV Ratio	1.62	1.51	1.10	0.65	0.87	0.30
P/FCF Ratio	21.64	30.00	6.11	14.01	29.10	-
P/OCF Ratio	20.34	25.86	5.81	12.46	20.56	-
PEG Ratio	-	0.32	0.32	0.32	0.32	0.32
EV/Sales Ratio	1.35	1.27	0.82	0.51	0.57	0.06
EV/EBITDA Ratio	25.21	12.28	12.00	6.12	7.53	-
EV/EBIT Ratio	50.75	16.49	19.24	8.80	10.57	-
EV/FCF Ratio	17.88	24.46	4.83	13.71	31.01	-
Debt / Equity Ratio	0.07	0.06	0.13	0.17	0.16	0.19
Debt / EBITDA Ratio	1.34	0.60	1.66	1.60	1.31	-
Debt / FCF Ratio	0.94	1.23	0.70	3.64	5.44	-
Asset Turnover	0.82	0.81	0.82	0.92	1.16	1.12
Inventory Turnover	4.40	3.41	2.78	2.05	2.52	3.18
Quick Ratio	2.63	2.07	2.47	1.52	0.90	0.96
Current Ratio	3.64	3.60	3.51	3.08	2.89	2.47
Return on Equity (ROE)	2.99%	6.26%	4.60%	7.08%	5.91%	-5.04%
Return on Assets (ROA)	1.32%	3.88%	2.18%	3.31%	3.89%	-1.86%
Return on Capital (ROIC)	1.48%	4.40%	2.54%	4.00%	4.79%	-2.29%
Return on Capital Employed (ROCE)	2.50%	7.30%	4.20%	6.60%	7.90%	-
Earnings Yield	1.83%	4.06%	4.32%	10.73%	6.61%	-13.89%
FCF Yield	4.62%	3.33%	16.36%	7.14%	3.44%	-9.00%
Dividend Yield	0.74%	0.81%	-	-	-	-
Payout Ratio	40.56%	-	-	-	-	-
Total Shareholder Return	0.74%	0.81%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.